FNArena

Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive ...

Kazia Therapeutics Limited: Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration ...

How one principal used debate to turn a failing middle school around

Facing enrollment decline, a Brooklyn middle school transforms after a former high school debate coach took the lead.
WUSF Public Media

Under federal pressure, public schools convert Latinos in Action into generic leadership classes

Latinos in Action, or LIA, is run by a national nonprofit with the same name that "operates as a year-long elective course taught by a highly-qualified teacher at the middle school, junior high and ...